Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy
Many clients feel refreshed right away
The most common cause of anemia is not having enough iron
Phase 3: Optimize both (weeks 9-16) Increase AOD 9604 to 300-500mcg daily based on tolerance
The peptides selective mechanism distinguishes it from broader-acting hormonal therapies with more complex side effect profiles
The comprehensive testing approach supports research integrity by ensuring scientists working with 5 Amino 1MQ have access to verified high-quality compounds that meet their experimental requirements
US$ 23.58
:max_bytes(150000):strip_icc()/Health-GettyImages-2189150331-f83c2e1aeae1458eae160de35bb91fd8.jpg)
US$ 20.27
US$ 26.55
